Inactive Instrument

News Stellar Biotechnologies Inc Toronto S.E.

Equities

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference	Apr. 12	AQ
Edesa Biotech to Participate in Barclays Global Healthcare Conference	Mar. 08	AQ
Top Premarket Gainers	Mar. 05	MT
Edesa Biotech, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 09	CI
Edesa Biotech, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 15	CI
Top Premarket Decliners	Dec. 13	MT
HC Wainwright Adjusts Price Target on Edesa Biotech to $21 From $70, Keeps Buy Rating	Nov. 29	MT
Top Premarket Gainers	Nov. 22	MT
Edesa Biotech, Inc. Reports Final Phase 2b Results for Dermatitis Study	Nov. 20	CI
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug	23-10-26	AQ
Edesa Biotech, Inc. Approves Updated Phase 3 Trial Design for Edesa Biotech?S ARDS Drug	23-10-25	CI
Top Premarket Decliners	23-10-13	MT
Sector Update: Health Care Stocks Decline in Late Afternoon	23-10-12	MT
Sector Update: Health Care	23-10-12	MT
Top Midday Gainers	23-10-12	MT
Edesa Biotech, Inc. to Receive Up to CAD 23 Million in Funding from Federal Government	23-10-12	CI
Edesa Biotech to Implement 1-for-7 Reverse Share Split; Stock Declines	23-10-10	MT
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate	23-09-29	AQ
Edesa Biotech, Inc. Publishes Phase 2 Substudy Results of ARDS Drug Candidate	23-09-28	CI
HC Wainwright Adjusts Edesa Biotech Price Target to $10 From $16, Maintains Buy Rating	23-08-15	MT

No results for this search